Replies to post #3591 on Medite Cancer Diagnostics Inc (MDIT)

[MasterSalix]

So this one will have just under 2 billion outstanding after the merger in March. What ya think that will do to the share price? With 2 B outstanding @ .04 you are talking an$80m M/C - new company has only $10m in revenue. I don't know much, but it is pretty clear they will need to R/S this one eventually - prob 100:1. Either that or we are looking at ultra- sub penny.